middle.news
Cleo Diagnostics Advances to Analytical Validation Phase
9:10am on Monday 13th of July, 2026 AEST
•
Healthcare
Read Story
Cleo Diagnostics Advances to Analytical Validation Phase
9:10am on Monday 13th of July, 2026 AEST
Key Points
Analytical validation phase commenced following assay development
Three-batch validation to demonstrate assay reproducibility
Clinical validation preparations underway for FDA submission
FDA submission targeted for first half of 2027
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE